vs

Side-by-side financial comparison of JBT Marel Corp (JBTM) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

JBT Marel Corp is the larger business by last-quarter revenue ($1.0B vs $309.9M, roughly 3.3× OMNICELL, INC.). JBT Marel Corp runs the higher net margin — 5.3% vs 3.7%, a 1.6% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 14.9%). JBT Marel Corp produced more free cash flow last quarter ($83.5M vs $38.6M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 5.8%).

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

JBTM vs OMCL — Head-to-Head

Bigger by revenue
JBTM
JBTM
3.3× larger
JBTM
$1.0B
$309.9M
OMCL
Growing faster (revenue YoY)
JBTM
JBTM
+100.7% gap
JBTM
115.6%
14.9%
OMCL
Higher net margin
JBTM
JBTM
1.6% more per $
JBTM
5.3%
3.7%
OMCL
More free cash flow
JBTM
JBTM
$44.9M more FCF
JBTM
$83.5M
$38.6M
OMCL
Faster 2-yr revenue CAGR
JBTM
JBTM
Annualised
JBTM
60.3%
5.8%
OMCL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
JBTM
JBTM
OMCL
OMCL
Revenue
$1.0B
$309.9M
Net Profit
$53.1M
$11.4M
Gross Margin
34.5%
45.3%
Operating Margin
7.2%
Net Margin
5.3%
3.7%
Revenue YoY
115.6%
14.9%
Net Profit YoY
858.6%
261.7%
EPS (diluted)
$1.04
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JBTM
JBTM
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$1.0B
$314.0M
Q3 25
$1.0B
$310.6M
Q2 25
$934.8M
$290.6M
Q1 25
$854.1M
$269.7M
Q4 24
$467.6M
$306.9M
Q3 24
$453.8M
$282.4M
Q2 24
$402.3M
$276.8M
Net Profit
JBTM
JBTM
OMCL
OMCL
Q1 26
$11.4M
Q4 25
$53.1M
Q3 25
$66.0M
$5.5M
Q2 25
$3.4M
$5.6M
Q1 25
$-173.0M
$-7.0M
Q4 24
$-7.0M
Q3 24
$38.9M
$8.6M
Q2 24
$30.7M
$3.7M
Gross Margin
JBTM
JBTM
OMCL
OMCL
Q1 26
45.3%
Q4 25
34.5%
41.5%
Q3 25
35.9%
43.3%
Q2 25
35.8%
43.9%
Q1 25
34.2%
41.1%
Q4 24
38.4%
46.2%
Q3 24
36.1%
43.3%
Q2 24
35.6%
41.3%
Operating Margin
JBTM
JBTM
OMCL
OMCL
Q1 26
Q4 25
7.2%
0.1%
Q3 25
10.2%
2.7%
Q2 25
5.2%
2.8%
Q1 25
-3.9%
-4.3%
Q4 24
3.4%
4.0%
Q3 24
10.3%
2.3%
Q2 24
6.7%
1.2%
Net Margin
JBTM
JBTM
OMCL
OMCL
Q1 26
3.7%
Q4 25
5.3%
Q3 25
6.6%
1.8%
Q2 25
0.4%
1.9%
Q1 25
-20.3%
-2.6%
Q4 24
-1.5%
Q3 24
8.6%
3.1%
Q2 24
7.6%
1.3%
EPS (diluted)
JBTM
JBTM
OMCL
OMCL
Q1 26
$0.25
Q4 25
$1.04
$-0.05
Q3 25
$1.26
$0.12
Q2 25
$0.07
$0.12
Q1 25
$-3.35
$-0.15
Q4 24
$-0.22
$0.34
Q3 24
$1.21
$0.19
Q2 24
$0.95
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JBTM
JBTM
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$167.9M
$239.2M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$4.5B
$1.3B
Total Assets
$8.2B
$2.0B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JBTM
JBTM
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$167.9M
$196.5M
Q3 25
$180.1M
Q2 25
$399.0M
Q1 25
$386.8M
Q4 24
$1.2B
$369.2M
Q3 24
$570.6M
Q2 24
$556.8M
Total Debt
JBTM
JBTM
OMCL
OMCL
Q1 26
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$2.0B
Q4 24
$1.3B
Q3 24
$648.3M
Q2 24
$647.7M
Stockholders' Equity
JBTM
JBTM
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$4.5B
$1.2B
Q3 25
$4.4B
$1.2B
Q2 25
$4.4B
$1.3B
Q1 25
$4.1B
$1.3B
Q4 24
$1.5B
$1.2B
Q3 24
$1.6B
$1.2B
Q2 24
$1.5B
$1.2B
Total Assets
JBTM
JBTM
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$8.2B
$2.0B
Q3 25
$8.2B
$1.9B
Q2 25
$8.3B
$2.1B
Q1 25
$8.0B
$2.2B
Q4 24
$3.4B
$2.1B
Q3 24
$2.8B
$2.3B
Q2 24
$2.7B
$2.3B
Debt / Equity
JBTM
JBTM
OMCL
OMCL
Q1 26
Q4 25
0.33×
Q3 25
0.34×
Q2 25
0.35×
Q1 25
0.48×
Q4 24
0.81×
Q3 24
0.41×
Q2 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JBTM
JBTM
OMCL
OMCL
Operating Cash FlowLast quarter
$117.4M
$54.5M
Free Cash FlowOCF − Capex
$83.5M
$38.6M
FCF MarginFCF / Revenue
8.3%
12.5%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
2.21×
4.80×
TTM Free Cash FlowTrailing 4 quarters
$238.1M
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JBTM
JBTM
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$117.4M
$30.4M
Q3 25
$87.7M
$28.3M
Q2 25
$102.2M
$42.8M
Q1 25
$34.4M
$25.9M
Q4 24
$128.7M
$56.3M
Q3 24
$71.9M
$22.8M
Q2 24
$21.6M
$58.7M
Free Cash Flow
JBTM
JBTM
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$83.5M
$22.6M
Q3 25
$56.5M
$18.5M
Q2 25
$83.7M
$31.0M
Q1 25
$14.4M
$14.8M
Q4 24
$118.7M
$47.2M
Q3 24
$65.0M
$13.9M
Q2 24
$11.1M
$49.1M
FCF Margin
JBTM
JBTM
OMCL
OMCL
Q1 26
12.5%
Q4 25
8.3%
7.2%
Q3 25
5.6%
6.0%
Q2 25
9.0%
10.7%
Q1 25
1.7%
5.5%
Q4 24
25.4%
15.4%
Q3 24
14.3%
4.9%
Q2 24
2.8%
17.8%
Capex Intensity
JBTM
JBTM
OMCL
OMCL
Q1 26
Q4 25
3.4%
2.5%
Q3 25
3.1%
3.1%
Q2 25
2.0%
4.1%
Q1 25
2.3%
4.1%
Q4 24
2.1%
3.0%
Q3 24
1.5%
3.1%
Q2 24
2.6%
3.5%
Cash Conversion
JBTM
JBTM
OMCL
OMCL
Q1 26
4.80×
Q4 25
2.21×
Q3 25
1.33×
5.18×
Q2 25
30.06×
7.58×
Q1 25
Q4 24
Q3 24
1.85×
2.64×
Q2 24
0.70×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JBTM
JBTM

Segment breakdown not available.

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons